Home » Newsletters » BioWorld

BioWorld

June 19, 2003

View Archived Issues

Introgen Collects $11.5M With Private Sale Of Common Stock

Introgen Therapeutics Inc. raised $11.5 million Wednesday through the private placement of 2 million common shares. (BioWorld Today) Read More

Senate Bill Addresses Medicare Reimbursement On Biologics

A Protein, RKIP, Inhibits Prostate Cancer Tumor Cells From Riding Blood Vessels To Metastatic Goal

Visit BioWorld At BIO 2003

Correction

Sunol Moves Sunol-cH36 Into Clinic; Fund-Raising In Works

Other News To Note

U.S. Patent Disclosures